LSL Pharma Group Inc. (TSXV:LSL)
0.3150
-0.0050 (-1.56%)
Sep 18, 2026, 3:10 PM EST
| Market Cap | 39.92M -13.3% |
| Revenue (ttm) | 41.83M +80.0% |
| Net Income | -7.34M |
| EPS | -0.06 |
| Shares Out | 126.73M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,500 |
| Open | 0.3200 |
| Previous Close | 0.3200 |
| Day's Range | 0.3150 - 0.3200 |
| 52-Week Range | 0.3000 - 0.5600 |
| Beta | -0.52 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 25, 2026 |